Aurora Cannabis Inc (NASDAQ:ACB) — Market Cap & Net Worth

$236.15 Million USD · Rank #16022

Market Cap & Net Worth: Aurora Cannabis Inc (ACB)

Aurora Cannabis Inc (NASDAQ:ACB) has a market capitalization of $236.15 Million ($236.15 Million) as of September 23, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16022 globally and #3800 in its home market, demonstrating a 12.07% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aurora Cannabis Inc's stock price $4.27 by its total outstanding shares 63310061 (63.31 Million). Also see balance sheet size of Aurora Cannabis Inc for a full breakdown of the balance sheet.

Aurora Cannabis Inc Market Cap History: 2015 to 2026

Aurora Cannabis Inc's market capitalization history from 2015 to 2026. Data shows change from $3.15 Billion to $270.33 Million (-17.48% CAGR). Also see Aurora Cannabis Inc cash flow conversion for how efficiently the company converts equity into cash flow.

Index Memberships

Aurora Cannabis Inc is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.66 Trillion	0.01%	#439 of 976
NASDAQ Composite IXIC	$42.40 Trillion	0.00%	#1574 of 3165

Weight: Aurora Cannabis Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Aurora Cannabis Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Aurora Cannabis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Aurora Cannabis Inc for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.84x

Aurora Cannabis Inc's market cap is 0.84 times its annual revenue

Industry average: 0.64x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2017	$57.32 Billion	$18.07 Million	-$12.97 Million	3172.56x	N/A
2018	$37.68 Billion	$55.20 Million	$71.94 Million	682.70x	523.83x
2019	$16.41 Billion	$245.54 Million	-$293.51 Million	66.83x	N/A
2020	$5.26 Billion	$268.70 Million	-$3.28 Billion	19.58x	N/A
2021	$3.43 Billion	$245.25 Million	-$693.62 Million	13.97x	N/A
2022	$584.10 Million	$221.34 Million	-$1.74 Billion	2.64x	N/A
2023	$301.48 Million	$223.80 Million	-$816.63 Million	1.35x	N/A
2024	$269.07 Million	$270.28 Million	-$69.33 Million	1.00x	N/A
2025	$267.17 Million	$343.29 Million	$1.59 Million	0.78x	167.92x
2026	$270.33 Million	$320.59 Million	-$121.76 Million	0.84x	N/A

Competitor Companies of ACB by Market Capitalization

Companies near Aurora Cannabis Inc in the global market cap rankings as of September 23, 2026. Review tangible equity quality of Aurora Cannabis Inc to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Aurora Cannabis Inc by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#524	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#586	GALDERMA GROUP AG	NYSE:GALDY	$46.44 Billion	$39.83
#638	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.50
#651	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$42.68 Billion	CN¥45.72

Aurora Cannabis Inc Historical Marketcap From 2015 to 2026

Between 2015 and today, Aurora Cannabis Inc's market cap moved from $3.15 Billion to $ 270.33 Million, with a yearly change of -17.48%.

Year	Market Cap	Change (%)
2026	$270.33 Million	+1.18%
2025	$267.17 Million	-0.71%
2024	$269.07 Million	-10.75%
2023	$301.48 Million	-48.38%
2022	$584.10 Million	-82.95%
2021	$3.43 Billion	-34.90%
2020	$5.26 Billion	-67.94%
2019	$16.41 Billion	-56.45%
2018	$37.68 Billion	-34.26%
2017	$57.32 Billion	+343.60%
2016	$12.92 Billion	+310.11%
2015	$3.15 Billion	--

End of Day Market Cap According to Different Sources

On Sep 23rd, 2026 the market cap of Aurora Cannabis Inc was reported to be:

Source	Market Cap
Yahoo Finance	$236.15 Million USD
MoneyControl	$236.15 Million USD
MarketWatch	$236.15 Million USD
marketcap.company	$236.15 Million USD
Reuters	$236.15 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic

Market Cap

$270.33 Million

Market Cap Rank

#16022 Global

#3800 in USA

Share Price

$4.27

Change (1 day)

+5.96%

52-Week Range

$2.58 - $6.23

All Time High

$1416.62